Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AYP-101 for reduction of submental fat
NCT05266729Phase 2Completed
- Sponsor
- AMIpharm
- Start
- Mar 2022
- Primary completion
- Dec 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of polyene phosphatidylcholine in submental fat, sponsored by AMIpharm. Started Mar 2022; status: completed.
02
Drugs
polyene phosphatidylcholine
03
Conditions
submental fat
Beyond the preview
Go deeper on NCT05266729.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05266729.